A new trading day began on Monday, with Imunon Inc (NASDAQ: IMNN) stock price down -14.06% from the previous day of trading, before settling in for the closing price of $0.61. IMNN’s price has ranged from $0.37 to $3.65 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 32.54% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 42.44%. With a float of $17.77 million, this company’s outstanding shares have now reached $20.32 million.
In an organization with 25 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Imunon Inc (IMNN) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Imunon Inc is 12.56%, while institutional ownership is 7.94%. The most recent insider transaction that took place on Aug 20 ’24, was worth 29,480. In this transaction Director of this company bought 25,000 shares at a rate of $1.18, taking the stock ownership to the 25,597 shares. Before that another transaction happened on Aug 15 ’24, when Company’s President and CEO bought 25,000 for $0.98, making the entire transaction worth $24,500. This insider now owns 264,166 shares in total.
Imunon Inc (IMNN) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.2 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 42.44% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 37.97% during the next five years compared to 32.54% growth over the previous five years of trading.
Imunon Inc (NASDAQ: IMNN) Trading Performance Indicators
Here are Imunon Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.88.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.41, a number that is poised to hit -0.32 in the next quarter and is forecasted to reach -0.42 in one year’s time.
Technical Analysis of Imunon Inc (IMNN)
Let’s dig in a bit further. During the last 5-days, its volume was 1.17 million. That was inferior than the volume of 5.5 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 3.17%.
During the past 100 days, Imunon Inc’s (IMNN) raw stochastic average was set at 5.38%, which indicates a significant increase from 1.13% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0756 in the past 14 days, which was lower than the 0.1471 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0494, while its 200-day Moving Average is $0.9411. However, in the short run, Imunon Inc’s stock first resistance to watch stands at $0.5783. Second resistance stands at $0.6367. The third major resistance level sits at $0.6683. If the price goes on to break the first support level at $0.4883, it is likely to go to the next support level at $0.4567. Assuming the price breaks the second support level, the third support level stands at $0.3983.
Imunon Inc (NASDAQ: IMNN) Key Stats
With a market capitalization of 10.57 million, the company has a total of 17,542K Shares Outstanding. Currently, annual sales are 0 K while annual income is -18,620 K. The company’s previous quarter sales were 0 K while its latest quarter income was -4,100 K.
